CVSG Share Price Performance
UK£12.14
3.44 (39.54%)
26.9% undervalued intrinsic discount
UK£16.62
Fair Value
Price UK£12.14
AnalystConsensusTarget UK£16.62
AnalystLowTarget UK£12.50
AnalystHighTarget UK£20.00
Fair ValueUK£16.62
Share Pricen/a
CVS Group plc Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 23 Fair Values set on narratives written by author
CVSG Community Narratives
AN
Fair Value UK£16.62 26.9% undervalued intrinsic discount
CVSG: Shares Will Gain From Buyback Programme and Dividend Increase
0users have liked this narrative
0users have commented on this narrative
13users have followed this narrative
AN
Fair Value UK£12.5 2.9% undervalued intrinsic discount
Rising Costs And Regulatory Threats Will Erode Fundamentals
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value UK£19.65 38.2% undervalued intrinsic discount
Rising Pet Ownership And Digital Integration Will Transform Veterinary Care
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
CVSG: Shares Will Gain From Buyback Programme and Dividend Increase
Key Takeaways Expansion into the Australian market aims to boost revenue and EBITDA through strategic acquisitions and synergies. Improvement in customer engagement and service delivery is expected to enhance client retention and increase sales.Read more
0users have liked this narrative
0users have commented on this narrative
13users have followed this narrative
AN
UK£16.62
26.9% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue
5.37% p.a.
Profit Margin
6.77%
Future PE
27.17x
Price in 2028
UK£20.19
Rising Pet Ownership And Digital Integration Will Transform Veterinary Care
Key Takeaways Accelerating synergy benefits and digital enhancements are driving faster-than-expected margin expansion and creating underappreciated opportunities for recurring revenue growth. Favourable industry trends and a strong clinical reputation position the company for sustained growth, enhanced pricing power, and strategic consolidation opportunities.Read more
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
UK£19.65
38.2% undervalued intrinsic discount
AnalystHighTarget Fair Value
Revenue
6.51% p.a.
Profit Margin
6.88%
Future PE
30.59x
Price in 2028
UK£23.7
Rising Costs And Regulatory Threats Will Erode Fundamentals
Key Takeaways Demographic shifts, regulatory pressures, and technological disruption threaten to erode core revenue drivers and compress operating margins. Heavy reliance on acquisitions increases balance sheet risk and raises the potential for integration failures and earnings instability.Read more
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
UK£12.5
2.9% undervalued intrinsic discount
AnalystLowTarget Fair Value
Revenue
6.33% p.a.
Profit Margin
6.77%
Future PE
19.79x
Price in 2028
UK£15
Trending Discussion
Recently Updated Narratives
AN
CVSG: Higher Price Objective Will Drive Returns Through Margin Expansion
Fair Value: UK£16.62 26.9% undervalued intrinsic discount
13 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Rising Costs And Regulatory Threats Will Erode Fundamentals
Fair Value: UK£12.5 2.9% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Rising Pet Ownership And Digital Integration Will Transform Veterinary Care
Fair Value: UK£19.65 38.2% undervalued intrinsic discount
2 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
CVS Group plc Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Feb 26, 2026
- 0.27
- 42.44%
- 2.81%
- 48.1%
About CVSG
- Founded
- 1999
- Employees
- 8850
- CEO
- WebsiteView website
CVS Group plc, together with its subsidiaries, engages in veterinary, online pharmacy, and retail businesses in the United Kingdom and Australia. It operates through the Veterinary Practices, Laboratories, and Online Retail Business segments. The company is involved in animal veterinary practices and complementary veterinary diagnostic businesses. It also operates Animed Direct, an online retail business that sells prescription and non-prescription medicines, pet foods, and other pet care products, as well as an online dispensary. In addition, the company provides veterinary instrumentation supply and property development services. The company was founded in 1999 and is headquartered in Diss, the United Kingdom.
